Omada Health (OMDA) EBIT Margin (2024 - 2026)

Omada Health (OMDA) has 3 years of EBIT Margin data on file, last reported at 6.13% in Q1 2026.

• For the quarter ending Q1 2026, EBIT Margin rose 915.0% year-over-year to 6.13%; the trailing twelve-month figure through Mar 2026 stood at 2.95% (up 1501.0% YoY), and the FY2025 full-year result was 4.6%, up 2111.0% from the prior year.
• EBIT Margin slipped to 6.13% in Q1 2026, from 4.33% in the prior quarter.
• In the past five years, EBIT Margin ranged from a high of 4.33% in Q4 2025 to a low of 24.35% in Q2 2024.
• A 3-year average of 10.72% and a median of 10.94% in 2024 frame the typical range for EBIT Margin.
• Across the five-year window, EBIT Margin jumped 1912 bps in 2025 and soared 915 bps in 2026, its largest moves.
• Tracing OMDA's EBIT Margin over 3 years: stood at 14.8% in 2024, then soared by 129 bps to 4.33% in 2025, then plunged by 242 bps to 6.13% in 2026.
• Business Quant data shows OMDA's EBIT Margin at 6.13% in Q1 2026, 4.33% in Q4 2025, and 3.69% in Q3 2025.